ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Jazz Pharmaceuticals, INC.

Official 2024 U.S. DOL Form 5500 summary for Jazz Pharmaceuticals, INC. (Jazz Pharmaceuticals, INC. 401k Plan · EIN 05-0563787 · PN 001): $373.78M net assets, 1,473 active participants, and $3.02 per $10,000 (3.02 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorJazz Pharmaceuticals, INC.
Filing IdentifierJazz Pharmaceuticals, INC. 401k Plan · EIN 05-0563787 · PN 001
Plan Category & State401(k) Defined Contribution (CA)
Asset-Size Peer Cohort$100M-$500M
Plan Net Assets (2024)$373.78M
Active Participants1,473
Direct Admin Fee Rate$3.02 per $10,000 (3.02 bps)
Cohort Peer Median$9.75 per $10,000 (9.75 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI

Cross-Agency Entity Graph

Related Filings Across Meru Platforms

Verified federal filings reconciled for Jazz Pharmaceuticals across sibling Meru AI platforms.